Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000220.KS Stock Summary
Top 10 Correlated ETFs
000220.KS
In the News
000220.KS Financial details
Company Rating
Buy
Market Cap
81.67B
Income
-7.54B
Revenue
137.34B
Book val./share
-
Cash/share
-
Dividend
105
Dividend %
2.06%
Employees
344
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-11.06
Forward P/E
-
PEG
-0.16
P/S
0.61
P/B
0.74
P/C
-
P/FCF
-4.96
Quick Ratio
-
Current Ratio
1.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-466.34
EPS next Y
-
EPS next Q
-
EPS this Y
362.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
10.82%
Revenue Q/Q
-0.37%
EPS Q/Q
-23.38%
-
-
-
-
SMA20
16.17%
SMA50
6.08%
SMA100
0.98%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-
Gross Margin
37%
Oper. Margin
-
Profit Margin
-5%
Payout
-
Shs Outstand
16.35M
Shs Float
10.54M
-
-
-
-
Target Price
-
52W Range
4160.0-6880.0
52W High
-26.31%
52W Low
+21.88%
RSI
56.49
Rel Volume
1.12
Avg Volume
364.08K
Volume
408.03K
Perf Week
-0.39%
Perf Month
15.23%
Perf Quarter
-9.14%
Perf Half Y
-12.89%
-
-
-
-
Beta
0.614
-
-
Volatility
190.11%, 332.95%
Prev Close
-3.24%
Price
5070
Change
3.15%
000220.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.6K | 7.27K | 7.9K | 7.25K | 8.38K | |
Net income per share | 319.5 | 378 | 194.34 | -57.67 | -266.9 | |
Operating cash flow per share | 485.58 | 1.06K | -215 | 282.51 | -375.68 | |
Free cash flow per share | -314.68 | 356.11 | -1.37K | -140.5 | -711.47 | |
Cash per share | 2.19K | 1.93K | 1.65K | 3.15K | 1.86K | |
Book value per share | 6.82K | 7.1K | 9.21K | 7.79K | 7.05K | |
Tangible book value per share | 6.77K | 7.09K | 9.12K | 7.8K | 7.22K | |
Share holders equity per share | 6.82K | 7.1K | 9.21K | 7.79K | 7.05K | |
Interest debt per share | 2.25K | 2.3K | 1.75K | 2.59K | 2.52K | |
Market cap | 64.49B | 70.9B | 90.62B | 124.64B | 103.13B | |
Enterprise value | 64.73B | 70.99B | 90.25B | 113.54B | 116.57B | |
P/E ratio | 16.04 | 15.01 | 37.56 | -135.44 | -23.3 | |
Price to sales ratio | 0.78 | 0.78 | 0.92 | 1.08 | 0.74 | |
POCF ratio | 10.55 | 5.38 | -33.95 | 27.64 | -16.56 | |
PFCF ratio | -16.29 | 15.94 | -5.34 | -55.59 | -8.74 | |
P/B Ratio | 0.75 | 0.8 | 0.79 | 1 | 0.88 | |
PTB ratio | 0.75 | 0.8 | 0.79 | 1 | 0.88 | |
EV to sales | 0.78 | 0.78 | 0.92 | 0.98 | 0.84 | |
Enterprise value over EBITDA | 7.88 | 6.44 | 9.68 | 15.87 | 20.38 | |
EV to operating cash flow | 10.59 | 5.38 | -33.81 | 25.18 | -18.71 | |
EV to free cash flow | -16.35 | 15.96 | -5.32 | -50.64 | -9.88 | |
Earnings yield | 0.06 | 0.07 | 0.03 | -0.01 | -0.04 | |
Free cash flow yield | -0.06 | 0.06 | -0.19 | -0.02 | -0.11 | |
Debt to equity | 0.32 | 0.3 | 0.17 | 0.32 | 0.34 | |
Debt to assets | 0.2 | 0.2 | 0.13 | 0.2 | 0.2 | |
Net debt to EBITDA | 0.03 | 0.01 | -0.04 | -1.55 | 2.35 | |
Current ratio | 2.48 | 1.53 | 3.5 | 3.29 | 1.5 | |
Interest coverage | 4.75 | 4.52 | 3.57 | 1.22 | 0.27 | |
Income quality | 1.42 | 2.37 | -1.11 | -4.9 | 1.41 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Payout ratio | 0.34 | 0.31 | 0.63 | -2.01 | -0.46 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | |
Research and developement to revenue | 0.02 | 0.01 | 0.04 | 0.03 | 0.06 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -1.65 | -0.66 | 5.35 | -1.5 | 0.89 | |
Capex to revenue | -0.12 | -0.1 | -0.15 | -0.06 | -0.04 | |
Capex to depreciation | -4.73 | -2.8 | -3.66 | -1.5 | -1.11 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7K | 7.77K | 6.35K | 3.18K | 6.5K | |
ROIC | 0.04 | 0.06 | 0.03 | 0.04 | 0.01 | |
Return on tangible assets | 0.03 | 0.03 | 0.02 | 0 | -0.02 | |
Graham Net | 485.05 | 95.62 | 754.71 | 987.2 | -130.02 | |
Working capital | 41.08B | 22.56B | 46.07B | 68.87B | 32.04B | |
Tangible asset value | 85.17B | 88.57B | 113.2B | 124.55B | 119.66B | |
Net current asset value | 20.52B | 17.88B | 26.6B | 34.59B | 24.53B | |
Invested capital | 0.32 | 0.3 | 0.17 | 0.32 | 0.34 | |
Average receivables | 24.54B | 23.3B | 20.46B | 21.38B | 24.11B | |
Average payables | 6.76B | 5.72B | 5.84B | 7.13B | 12.41B | |
Average inventory | 17.6B | 16.32B | 20.35B | 24.46B | 32.53B | |
Days sales outstanding | 112.08 | 84.66 | 73.83 | 72.29 | 66.52 | |
Days payables outstanding | 43.47 | 52.65 | 36.51 | 46.62 | 67.57 | |
Days of inventory on hand | 134.24 | 140.3 | 163.6 | 130.93 | 169.91 | |
Receivables turnover | 3.26 | 4.31 | 4.94 | 5.05 | 5.49 | |
Payables turnover | 8.4 | 6.93 | 10 | 7.83 | 5.4 | |
Inventory turnover | 2.72 | 2.6 | 2.23 | 2.79 | 2.15 | |
ROE | 0.05 | 0.05 | 0.02 | -0.01 | -0.04 | |
Capex per share | -800.26 | -699.32 | -1.15K | -423.01 | -335.8 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.05K | 2.1K | 2.07K | 2.16K | 0 | |
Net income per share | -99.46 | -108.93 | 27.63 | -218 | 0 | |
Operating cash flow per share | -160.58 | -128.86 | -51.34 | -349.96 | 0 | |
Free cash flow per share | -194.4 | -255.3 | -131.86 | -451.18 | 0 | |
Cash per share | 2.17K | 1.86K | 1.65K | 1.65K | 0 | |
Book value per share | 7.05K | 7.05K | 6.86K | 7.3K | 0 | |
Tangible book value per share | 7.14K | 7.22K | 7.04K | 7.49K | 0 | |
Share holders equity per share | 7.05K | 7.05K | 6.86K | 7.3K | 0 | |
Interest debt per share | 2.43K | 2.35K | 2.58K | 2.94K | 0 | |
Market cap | 94.75B | 103.13B | 98.16B | 79.97B | 0 | |
Enterprise value | 98.2B | 116.57B | 114.5B | 100.88B | 0 | |
P/E ratio | -14.3 | -14.27 | 53.56 | -5.78 | 0 | |
Price to sales ratio | 2.78 | 2.97 | 2.86 | 2.34 | 0 | |
POCF ratio | -35.43 | -48.27 | -115.31 | -14.4 | 0 | |
PFCF ratio | -29.27 | -24.36 | -44.9 | -11.17 | 0 | |
P/B Ratio | 0.81 | 0.88 | 0.86 | 0.69 | 0 | |
PTB ratio | 0.81 | 0.88 | 0.86 | 0.69 | 0 | |
EV to sales | 2.88 | 3.36 | 3.34 | 2.95 | 0 | |
Enterprise value over EBITDA | 166.52 | 95.85 | 8.29 | 152.68 | 0 | |
EV to operating cash flow | -36.72 | -54.56 | -134.51 | -18.17 | 0 | |
EV to free cash flow | -30.33 | -27.54 | -52.37 | -14.09 | 0 | |
Earnings yield | -0.02 | -0.02 | 0 | -0.04 | 0 | |
Free cash flow yield | -0.03 | -0.04 | -0.02 | -0.09 | 0 | |
Debt to equity | 0.34 | 0.34 | 0.36 | 0.4 | 0 | |
Debt to assets | 0.21 | 0.2 | 0.21 | 0.23 | 0 | |
Net debt to EBITDA | 5.84 | 11.05 | 1.18 | 31.64 | 0 | |
Current ratio | 1.65 | 1.5 | 1.45 | 2.03 | 1.99 | |
Interest coverage | -0.72 | 0.4 | 1.09 | -0.42 | 0 | |
Income quality | 1.61 | 1.18 | -1.86 | 1.75 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.04 | 0.35 | 0.03 | 0.37 | |
Research and developement to revenue | 0.06 | 0.08 | 0.08 | 0.08 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Capex to operating cash flow | 0.21 | 0.98 | 1.57 | 0.29 | 0 | |
Capex to revenue | -0.02 | -0.06 | -0.04 | -0.05 | 0 | |
Capex to depreciation | -0.44 | -1.6 | -1.03 | -1.11 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.97K | 4.16K | 2.07K | 5.98K | 0 | |
ROIC | 0 | 0 | 0.01 | 0 | -0.01 | |
Return on tangible assets | -0.01 | -0.01 | 0 | -0.02 | -0.01 | |
Graham Net | 285.46 | -130.02 | -449.41 | -524.44 | 0 | |
Working capital | 37.24B | 32.04B | 30.24B | 50.79B | 46.82B | |
Tangible asset value | 118.86B | 119.66B | 116.66B | 118.89B | 120.8B | |
Net current asset value | 27.81B | 24.53B | 21.67B | 22.76B | 18.31B | |
Invested capital | 0.34 | 0.34 | 0.36 | 0.4 | 0 | |
Average receivables | 25.63B | 25.69B | 24.99B | 24.72B | 12.38B | |
Average payables | 10.73B | 13.32B | 15.97B | 14.96B | 6.9B | |
Average inventory | 30.53B | 36.04B | 42.46B | 47.05B | 24.5B | |
Days sales outstanding | 68.71 | 65.57 | 64.75 | 65.13 | 0 | |
Days payables outstanding | 43.79 | 67.74 | 70.79 | 57.32 | 0 | |
Days of inventory on hand | 130.72 | 170.34 | 198.18 | 203.49 | 0 | |
Receivables turnover | 1.31 | 1.37 | 1.39 | 1.38 | 0 | |
Payables turnover | 2.06 | 1.33 | 1.27 | 1.57 | 0 | |
Inventory turnover | 0.69 | 0.53 | 0.45 | 0.44 | 0 | |
ROE | -0.01 | -0.02 | 0 | -0.03 | -0.02 | |
Capex per share | -33.81 | -126.45 | -80.52 | -101.22 | 0 |
000220.KS Frequently Asked Questions
What is Yuyu Pharma, Inc. stock symbol ?
Yuyu Pharma, Inc. is a KR stock and trading under the symbol 000220.KS
What is Yuyu Pharma, Inc. stock quote today ?
Yuyu Pharma, Inc. stock price is $5070 today.
Is Yuyu Pharma, Inc. stock public?
Yes, Yuyu Pharma, Inc. is a publicly traded company.